SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Au... ( HORSHAM Pa. and KENILWORTH N.J. Oct. ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector

Date:10/6/2009

HORSHAM, Pa. and KENILWORTH, N.J., Oct. 6 /PRNewswire/ -- Centocor Ortho Biotech Inc. and Schering-Plough Corporation (NYSE: SGP) announced today that the European Commission has approved SIMPONI(TM) (golimumab) as a once-monthly, subcutaneous therapy for the treatment of moderate-to-severe, active rheumatoid arthritis (RA), active and progressive psoriatic arthritis (PsA) and severe, active ankylosing spondylitis (AS).

In the European Union, SIMPONI is approved as a 50 mg subcutaneous injection once a month and is indicated:

In combination with methotrexate, for the treatment of moderate-to-severe, active RA in adult patients when the response to disease-modifying anti-rheumatic drug (DMARD) therapy, including methotrexate, has been inadequate. SIMPONI has also been shown to improve physical function in this patient population.
Alone or in combination with methotrexate, for the treatment of active and progressive PsA in adult patients when the response to previous DMARD therapy has been inadequate. SIMPONI has also been shown to improve physical function in this patient population.
For the treatment of severe, active AS in adult patients who have responded inadequately to conventional therapy.

Centocor Ortho Biotech Inc. developed and discovered SIMPONI and has exclusive marketing rights to the product in the United States. Following regulatory approvals, Schering-Plough will assume exclusive marketing rights outside the United States except in Japan, Indonesia and Taiwan, where SIMPONI will be co-marketed by Mitsubishi Tanabe Pharma Corporation and Janssen Pharmaceutical Kabushiki Kaisha; Hong Kong, where SIMPONI will be exclusively marketed by Janssen-Cilag; and China, where SIMPONI will be exclusively marketed by Xian-Janssen. Centocor Ortho Biotech, Janssen-Cilag and Xian-Janss
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related medicine technology :

1. SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
2. New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients
3. Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
4. GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT(TM)
5. Sequella Receives American Recovery and Reinvestment Funding Through the NIH
6. Biostar Pharmaceuticals, Inc. Receives Patent for Aoxing Ganbao
7. Cortheras Relaxin Receives FDA Fast Track Designation for the Treatment of Acute Heart Failure
8. Sigma-Aldrich(R) Receives Award From Michael J. Fox Foundation to Develop Parkinsons Disease Research Models
9. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
10. GenVec Receives National Cancer Institute Grant to Expand Cancer Program
11. Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager

Post Your Comments:

(Date:5/20/2013)... WASHINGTON , May 20, 2013 Medicare ... networks are overwhelmingly satisfied, citing lower costs, convenient ... a new survey from Hart Research Associates released ... More than 40% of Part D seniors (9.5 ... networks. "Seniors like the lower costs, ...

(Date:5/19/2013)... 2013 Whole-cell pertussis vaccines were more effective at ... large recent outbreak, according to a new Kaiser Permanente ... also called DTwP, were available from the 1940s to ... led to the development of acellular pertussis vaccines, which ... the United States had switched from ...

(Date:5/17/2013)... -- The power of plants to cure and rejuvenate, ... depends on the plant kingdom, is the subject of ... Medicine: Healing Plants Around the World, Featuring ... 18 through September 8, 2013. (Photo: ... attractions include a re-creation of the Western world,s oldest ...

Breaking Medicine Technology:Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4 Wild Medicine On View at The New York Botanical Garden Through Sept. 8 2

[0] Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices [0] Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak [0] Wild Medicine On View at The New York Botanical Garden Through Sept. 8

... (OTC Bulletin Board: AEMD ), the pioneer ... and cancer, announced today that it has engaged Fabiani ... partnerships that advance biodefense, cancer, and chronic infectious disease ... the first medical device to selectively target the removal ...

... LAIYANG, China, Sept. 30 /PRNewswire-Asia-FirstCall/ -- ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...

Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results

(Date:5/20/2013)... New York (PRWEB) May 20, 2013 National ... Firm P.A. and Thrash Law Firm P.A., both based in ... final approval of the proposed $7.25 billion settlement of a ... transaction fees. The objection was filed Wednesday, May 15, 2013, ... New York. The related lawsuit against Visa and MasterCard (Case ...

(Date:5/20/2013)... is proud to announce the publication of the much-anticipated ... A. Weinberg. , The First Edition has been ... the most important advances in the fast-growing field of ... all of its hallmark features admired by students, instructors, ... of Cancer is a textbook for students studying the ...

(Date:5/20/2013)... 2013 For more than forty years, ... battle against drug and alcohol abuse around the world. ... first guide to help Italian speakers reverse growing trends ... European Monitoring Centre for Drugs and Drug Addiction show ... cannabis in the last year. As a glimpse of ...

(Date:5/20/2013)... -- A child whose mother lived near heavy traffic ... a respiratory infection before the age of 3, a ... nearly 1,300 pairs of mothers and infants from eastern ... their first trimester of pregnancy at some point between ... mothers lived within 100 meters (about 110 yards) from ...

(Date:5/20/2013)... fossa subdural hematoma (PFSDH) is a serious and rare ... with appropriate treatment, there,s an excellent chance of good ... a study in the May issue of ... of Neurological Surgeons . The journal is published by ... Wolters Kluwer Health . , The results support ...

Breaking Medicine News(10 mins):Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 2 Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 3 Health News:'The Biology of Cancer' by Robert A. Weinberg 2 Health News:First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth 2 Health News:Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children 2 Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 2 Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 3

[0] Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’[0] 'The Biology of Cancer' by Robert A. Weinberg [0] First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth [0] Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children [0] Study supports 'aggressive' treatment for posterior fossa hematoma in newborns

... 11 private healthcare providers into the public NHS system thereby ... sector. //Mr Blair and the health secretary, Patricia Hewitt, welcomed ... to mark the launch of NHS Partners Network. ... towards 'future success' of the NHS. "Wherever people are treated ...

... are at a lesser risk of Parkinson’s, according to ... and Psychiatry. // ,The research team, as ... patients and 106 healthy people, belonging to the same ... sought to throw light on their personality traits and ...

... flu pandemic could claim as much as 140 million ... ,The authors of the report, internationally renowned ... academic Alexandra Sidorenko, estimate that even a mild pandemic ... economy $330 billion in lost production. ,The ...

... in Australia claims to have discovered a novel way ... attention deficit hyperactivity disorder (ADHD). //This novel method, space-age ... space. But it can also be used by the ... , ,Attention deficit hyperactivity disorder (ADHD) is a ...

... firm LG Electronics has said that it will start to ... filter made from using an enzyme contained in the "the ... against the dreaded bird flu virus. ,"We developed ... flu," LG spokeswoman Park Se-won said. The filter was fabricated ...

... are pushing Wal-Mart against a Wall, to cough up more on ... the unions are doing this for the cause of the workers, ... meets the eye. The scene is on the brink of a ... ,The scene at Washington is hotting up with the ...

Cached Medicine News:

Blair Welcomes 11 Private Healthcare Providers into NHS Adventure Enthusiasts, Risk Takers and Those Living on the Edge, Good News Coming Your Way Bird Flu Could Claim 140 Million Lives: Report Novel Treatment to Cure People with Learning Disabilities,LG To Market Air Conditioner Capable of Fighting Bird Flu Upgrade Health Benefits: Wal-Mart in a Tight Spot

Compact, bench-top analyser with minimal water volume requirements and easy waste management....

... source is a superior choice for machine ... headlamps, and dental curing. This is a ... weight, compact and cost competitve with lower ... source utilizes the latest in Cermax technology, ...

... Test System* is a multiplexed, fluorescent, ... multiple assays from a single sample ... a simple and streamlined alternative to ... clinical sensitivity and comparable clinical specificity ...

... 350 Chemistry System offers easy operation, maintenance, and ... STAT, or back-up to the powerful VITROS 5,1 ... the job done right the first time. Its ... are efficient, dependable, and easy-to-use. The VITROS 350 ...

Medicine Products:

Mira XL2000 Fiber Optic Light Source AtheNA Multi-Lyte Test System VITROS 350 Chemistry System